GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,283,000 | -14.1% | 36,631 | 0.0% | 0.68% | -20.2% |
| Q1 2021 | $1,493,000 | -18.2% | 36,631 | -13.2% | 0.85% | -27.4% |
| Q4 2020 | $1,826,000 | -21.6% | 42,196 | 0.0% | 1.17% | -18.6% |
| Q3 2020 | $2,328,000 | -7.3% | 42,196 | +6.1% | 1.44% | -17.9% |
| Q2 2020 | $2,510,000 | +4.8% | 39,762 | -15.2% | 1.75% | -21.8% |
| Q1 2020 | $2,395,000 | -35.7% | 46,873 | 0.0% | 2.24% | -10.2% |
| Q4 2019 | $3,726,000 | +193.4% | 46,873 | +79.1% | 2.50% | +175.0% |
| Q3 2019 | $1,270,000 | – | 26,176 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |